Embolization, Inc.
PrivateLast Round
Grant
Nov 21, 2024
Total Funding Raised
$27.15M
Company Overview
Embolization, Inc. operates in Healthcare & Life Sciences and is based in Boulder, Colorado. Its latest recorded funding round was a Grant round in November 2024.
Embolization, Inc. is a medical device company that specializes in the development of minimally invasive medical devices for peripheral vascular and neurovascular uses in the interventional radiology market.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Embolization, Inc. Comparables
Compare Embolization, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Memory Medical | 83% | |
| Artio Medical | 82% | |
| Terumo Corporation | 74% |
For institutional investors. Book with your work email.
Embolization, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 21, 2024 | ||||
| Series B | Feb 8, 2017 | ||||
| Series B | Jun 20, 2014 | ||||
| Series B | Aug 27, 2012 | ||||
| Series B | Apr 13, 2011 | ||||
Grant | Oct 16, 2009 |
For institutional investors. Book with your work email.
Embolization, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Volcano Capital Management | Series B |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2024
Secured $250K in grant funding.
- Jun 20, 2014
$7M round led by Volcano Capital Management.
For institutional investors. Book with your work email.
Embolization, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Embolization, Inc.'s valuation, stock price, and market status.
Is Embolization, Inc. a public or private company?
Embolization, Inc. is a private company.
What is the current stock price of Embolization, Inc.?
Embolization, Inc. is a private company, so its shares have no public market price. Caplight tracks Embolization, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Embolization, Inc. worth (valuation)?
Valuation information for Embolization, Inc. is not publicly available.
Can I buy Embolization, Inc. stock?
Embolization, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Embolization, Inc.'s last funding round?
Embolization, Inc.'s most recent funding round was Grant on November 21, 2024.
Who are the main investors in Embolization, Inc.?
Key investors in Embolization, Inc. include Volcano Capital Management, National Science Foundation.
Will Embolization, Inc. IPO soon?
No public IPO plans have been announced for Embolization, Inc..
How can I track Embolization, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Embolization, Inc.'s shares on secondary markets.